1. Home
  2. RJF vs RMD Comparison

RJF vs RMD Comparison

Compare RJF & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RJF
  • RMD
  • Stock Information
  • Founded
  • RJF 1962
  • RMD 1989
  • Country
  • RJF United States
  • RMD United States
  • Employees
  • RJF N/A
  • RMD N/A
  • Industry
  • RJF Investment Bankers/Brokers/Service
  • RMD Medical/Dental Instruments
  • Sector
  • RJF Finance
  • RMD Health Care
  • Exchange
  • RJF Nasdaq
  • RMD Nasdaq
  • Market Cap
  • RJF 35.3B
  • RMD 35.7B
  • IPO Year
  • RJF N/A
  • RMD 1995
  • Fundamental
  • Price
  • RJF $171.49
  • RMD $249.81
  • Analyst Decision
  • RJF Buy
  • RMD Buy
  • Analyst Count
  • RJF 12
  • RMD 11
  • Target Price
  • RJF $156.09
  • RMD $243.50
  • AVG Volume (30 Days)
  • RJF 1.1M
  • RMD 743.9K
  • Earning Date
  • RJF 01-29-2025
  • RMD 01-30-2025
  • Dividend Yield
  • RJF 1.17%
  • RMD 0.85%
  • EPS Growth
  • RJF 21.71
  • RMD 22.60
  • EPS
  • RJF 9.70
  • RMD 7.54
  • Revenue
  • RJF $12,797,000,000.00
  • RMD $4,807,485,000.00
  • Revenue This Year
  • RJF $11.78
  • RMD $10.15
  • Revenue Next Year
  • RJF $7.19
  • RMD $7.30
  • P/E Ratio
  • RJF $17.68
  • RMD $33.78
  • Revenue Growth
  • RJF 11.18
  • RMD 9.88
  • 52 Week Low
  • RJF $104.24
  • RMD $170.56
  • 52 Week High
  • RJF $173.15
  • RMD $260.49
  • Technical
  • Relative Strength Index (RSI)
  • RJF 66.21
  • RMD 61.56
  • Support Level
  • RJF $166.07
  • RMD $243.23
  • Resistance Level
  • RJF $173.15
  • RMD $258.70
  • Average True Range (ATR)
  • RJF 3.38
  • RMD 5.36
  • MACD
  • RJF 1.27
  • RMD 2.29
  • Stochastic Oscillator
  • RJF 91.89
  • RMD 71.72

About RJF Raymond James Financial Inc.

Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company supports more than 8,000 employee and independent contractor financial advisors across the United States, Canada, and the United Kingdom with over $1.2 trillion of assets under administration as of September 2023. Approximately 90% of the company's revenue is from the US and 70% is from the company's wealth-management segment.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: